Home

MOXIFED-LB-625

MOXIFED-LB-625

Brand Name : MOXIFED-LB-625

Packing : 10*1*6

Composition : Amoxycilin 500mg + Potassium Clavulanate 125mg + Lactic Acid Bacillus Tablet

MOXIFED-LB-625 (Amoxicillin + Potassium Clavulanate + Lactic Acid Bacillus Tablet)

 

In the rapidly evolving pharmaceutical market, the demand for high-efficacy combination antibiotics is steadily rising. One such trusted and widely prescribed formulation is MOXIFED-LB-625, a powerful combination of Amoxicillin, Potassium Clavulanate, and Lactic Acid Bacillus. Manufactured and marketed by Fedley Healthcare, MOXIFED-LB-625 is a potent solution for a broad range of bacterial infections while maintaining gut health.

This document provides a detailed overview of MOXIFED-LB-625, its therapeutic profile, and why Fedley Healthcare is your ideal partner for a PCD pharma franchise.

Product Overview: MOXIFED-LB-625 Composition:

  • Amoxicillin Trihydrate IP equivalent to Amoxicillin 500 mg
     
  • Potassium Clavulanate IP equivalent to Clavulanic Acid 125 mg
     
  • Lactic Acid Bacillus spores 60 million spores
     

Form: Tablet

Packing: ALU-ALU Pack of 10 x 6 Tablets

Brand Name: MOXIFED-LB-625

Pharmacological Action

1. Amoxicillin (500 mg):

A broad-spectrum penicillin-type antibiotic that works by inhibiting bacterial cell wall synthesis, Amoxicillin is effective against a variety of Gram-positive and Gram-negative organisms.

2. Potassium Clavulanate (125 mg):

Clavulanic acid is a beta-lactamase inhibitor, which protects Amoxicillin from degradation by beta-lactamase-producing bacteria. This expands Amoxicillin’s spectrum of action to beta-lactamase resistant strains.

3. Lactic Acid Bacillus (60 million spores):

Probiotics like Lactic Acid Bacillus help restore the normal gut flora, preventing antibiotic-associated diarrhea, and maintaining gastrointestinal health during antibiotic therapy.

Indications

MOXIFED-LB-625 is indicated for the treatment of:

  • Acute sinusitis
     
  • Otitis media
     
  • Lower respiratory tract infections (e.g., bronchitis, pneumonia)
     
  • Urinary tract infections (UTIs)
     
  • Skin and soft tissue infections
     
  • Dental infections
     
  • Bone and joint infections
     
  • Gynecological infections
     

The inclusion of Lactic Acid Bacillus makes this formulation particularly useful in patients prone to gastrointestinal disturbances during antibiotic treatment.

 

Dosage and Administration

  • Usual adult dose: One tablet every 8–12 hours, or as directed by a physician.
     
  • Mode of intake: Preferably after meals to reduce gastric irritation.
     

Note: Dosage should be adjusted in patients with renal impairment and pediatric use requires special guidance.

Benefits of MOXIFED-LB-625

  1. Broad-spectrum efficacy against both gram-positive and gram-negative bacteria.
     
  2. Beta-lactamase inhibitor enhances antibiotic resistance coverage.
     
  3. Probiotic support reduces the risk of diarrhea and gut imbalance.
     
  4. High patient compliance with convenient dosing and better GI tolerance.
     
  5. Safe and effective for a wide range of infections with fewer side effects.

Side Effects and Precautions Possible Side Effects:

  • Nausea or vomiting
     
  • Diarrhea
     
  • Skin rash or allergic reactions
     
  • Abdominal cramps
     
  • Fungal superinfection (rare)
     
  • Altered liver enzymes (prolonged use)

Precautions:

  • History of penicillin allergy
     
  • Hepatic or renal impairment
     
  • Pregnancy and lactation (consult physician)
     
  • Long-term use may require liver and renal function monitoring

Why Choose Fedley Healthcare for MOXIFED-LB-625 Franchise?

At Fedley Healthcare, we don’t just offer products—we offer partnerships built on quality, trust, and growth. MOXIFED-LB-625 is a testament to our commitment to high-quality formulations, backed by advanced manufacturing and rigorous quality control.

Key Reasons to Partner with Us:

  1. WHO-GMP Certified Manufacturing: Ensures high product quality, safety, and compliance with international standards.
     
  2. Attractive Profit Margins: Competitive pricing allows franchise partners to achieve healthy returns.
     
  3. Exclusive Monopoly Rights: We offer region-specific monopoly rights to avoid competition among our own franchise holders.
     
  4. Extensive Product Portfolio: Along with MOXIFED-LB-625, we provide a wide range of antibiotics, injectables, syrups, and specialty products.
     
  5. Promotional Support: Includes visual aids, MR bags, literature, sample catch covers, reminder cards, and product training.
     
  6. Timely Dispatch: Strong logistics and inventory management ensure fast and reliable product delivery.
     
  7. Zero Compromise on Quality: From raw material sourcing to finished product packaging, every step is governed by strict QA/QC protocols.

Franchise Opportunity: Be a Part of Fedley’s Growing Network

Fedley Healthcare is offering PCD Pharma Franchise opportunities across India. Whether you're an experienced distributor, a passionate medical representative, or an entrepreneur looking to enter the pharmaceutical sector, we welcome you to join our success-driven network.

Franchise Support Includes:

  • Area-wise franchise rights
     
  • Timely product delivery and stock availability
     
  • Regular product updates and new launches
     
  • Marketing and promotional tools
     
  • Customer support and guidance
     
  • Freedom to operate independently
 

Target Audience for Franchise

  • Pharma distributors and wholesalers
     
  • Medical representatives
     
  • Healthcare entrepreneurs
     
  • Retail chemists/pharmacists
     
  • Clinic and hospital suppliers
     

We are actively looking to expand our footprint across urban, semi-urban, and rural areas, and invite partners who are enthusiastic and committed to healthcare excellence.

How to Apply for MOXIFED-LB-625 Franchise

You can get started in just a few steps:

  1. Reach Out: Contact our franchise team via phone or email.
     
  2. Discussion & Area Finalization: Choose your preferred region and get exclusive rights.
     
  3. Documentation: Submit basic legal and tax registration documents.
     
  4. Product Delivery: Receive your first consignment and marketing material.
     
  5. Start Operations: Begin promoting and distributing MOXIFED-LB-625 and other Fedley products in your territory.
 

Conclusion

MOXIFED-LB-625 by Fedley Healthcare is more than just a combination antibiotic—it is a thoughtfully developed formulation offering broad-spectrum action with gut protection, making it an essential prescription in today’s antimicrobial therapy landscape.

With high efficacy, strong market demand, and excellent patient compliance, it presents a lucrative business opportunity for pharma franchise partners.

Fedley Healthcare stands for innovation, integrity, and growth. Partner with us today and become a part of India’s progressive pharmaceutical future.